Trial Profile
Loteprednol etabonate/tobramycin vs loteprednol etabonate vs tobramycin in infants and children with blepharoconjuncitivitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2012
Price :
$35
*
At a glance
- Drugs Loteprednol etabonate/tobramycin (Primary) ; Loteprednol etabonate; Tobramycin
- Indications Bacterial infections; Blepharoconjunctivitis
- Focus Adverse reactions
- Sponsors Bausch & Lomb
- 22 Feb 2012 New trial record
- 01 Feb 2012 Results published in Pediatric Drugs.